Skip to content
★ Sign in to follow
AW

Andrew Wright

Hemogenyx Pharmaceuticals PLC
Total declarations
5
Company
1
▲ Purchases (5 ops.)
€65k
▼ Sales (0 ops.)
—

Latest filing published 19 May 2021 for Hemogenyx Pharmaceuticals PLC, €23k.

Filing timeline

BuySale
Andrew Wright

Insider track record

Disclosed buys
5
Disclosed sells
0
Signal history

Closed purchases

Market purchases
5

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Andrew Wright: trading record in brief

Andrew Wright appears in our data through filings on Hemogenyx Pharmaceuticals PLC shares, published by RNS (LSE). The record holds 5 filings, for trades running from 30 April 2019 to 18 May 2021.

The open-market record is one-sided, with 5 purchases worth €65k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2021, the count stands at 2 purchases and no sales.

Half of the purchases are above €6,646 and half below. Of 3 purchases, 1 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.

Most recently, on 19 May 2021, the filings show an open-market purchase worth €23k in Hemogenyx Pharmaceuticals PLC. The median gap between a trade and its publication by RNS (LSE) is 1 day. The regulation allows three business days to notify a trade (UK MAR). This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Andrew Wright

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations5 total
  • ▲
    PDMR: Financial Controller and Company SecretaryExecutivesHemogenyx Pharmaceuticals PLC
    19,900 GBP0FCA-NSM
    1,088,120 shares@ £0.0183London Stock Exchange XLONISIN GB00BYX3WZ24FCA-NSM:3978911
    Canonical exit: 16 Aug 2021 (T+90)
  • ▲
    PDMR: Financial Controller and Company SecretaryExecutivesHemogenyx Pharmaceuticals PLC
    5,721 GBP0FCA-NSM
    94,882 shares@ £0.0603London Stock Exchange XLONISIN GB00BYX3WZ24FCA-NSM:3903927
    Canonical exit: 6 Jun 2021 (T+90)
  • ▲
    PDMR: Financial Controller and Company SecretaryExecutivesHemogenyx Pharmaceuticals PLC
    5,143 GBP39FCA-NSM
    90,554 shares@ £0.0568100.0% of flowLondon Stock Exchange XLONISIN GB00BYX3WZ24FCA-NSM:3641510-0
    Canonical exit: 27 Sept 2020 (T+90)
  • ▲
    Financial Controller and Company Secretary/PDMR (non-board)ExecutivesHemogenyx Pharmaceuticals PLC
    5,000 GBP24FCA-NSM
    257,069 shares@ £0.019451.2% of flowLondon Stock Exchange XLONISIN GB00BYX3WZ24FCA-NSM:LSE20200131070005_14405233_20200331164953410_30379
    Canonical exit: 29 Apr 2020 (T+90)
  • ▲
    Financial Controller and Company Secretary/PDMR (non-board)ExecutivesHemogenyx Pharmaceuticals PLC
    20,000 GBP26FCA-NSM
    840,336 shares@ £0.023866.8% of flowLondon Stock Exchange XLONISIN GB00BYX3WZ24FCA-NSM:LSE20190501070014_14058463_20200326185143262_29646
    Canonical exit: 29 Jul 2019 (T+90)

5 of 5 declarations